MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

Nektar Therapeutics

Closed

41.3 -4.95

Overview

Share price change

24h

Current

Min

41.15

Max

43.66

Key metrics

By Trading Economics

Income

6.1M

-36M

Sales

615K

12M

EPS

-1.87

Profit margin

-301.289

Employees

61

EBITDA

6.9M

-29M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+138.36% upside

Market Stats

By TradingEconomics

Market Cap

-235M

905M

Previous open

46.25

Previous close

41.3

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 sty 2026, 23:08 UTC

Acquisitions, Mergers, Takeovers

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8 sty 2026, 21:39 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8 sty 2026, 20:54 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Restart Merger Talks -- Update

8 sty 2026, 20:44 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Restart Merger Talks

8 sty 2026, 17:05 UTC

Acquisitions, Mergers, Takeovers

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8 sty 2026, 16:43 UTC

Major Market Movers

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8 sty 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8 sty 2026, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8 sty 2026, 22:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 sty 2026, 22:42 UTC

Market Talk

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8 sty 2026, 22:30 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8 sty 2026, 21:53 UTC

Earnings

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 sty 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8 sty 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8 sty 2026, 21:10 UTC

Acquisitions, Mergers, Takeovers

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8 sty 2026, 21:09 UTC

Market Talk

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8 sty 2026, 21:09 UTC

Acquisitions, Mergers, Takeovers

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8 sty 2026, 20:21 UTC

Market Talk

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8 sty 2026, 19:44 UTC

Market Talk

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8 sty 2026, 18:50 UTC

Market Talk

Mexico's Industrial Production Seen Lower in November -- Market Talk

8 sty 2026, 17:48 UTC

Earnings

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 sty 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8 sty 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8 sty 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

8 sty 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 sty 2026, 16:45 UTC

Market Talk

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8 sty 2026, 16:03 UTC

Market Talk

Global Equities Roundup: Market Talk

8 sty 2026, 16:03 UTC

Market Talk

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8 sty 2026, 16:02 UTC

Market Talk

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8 sty 2026, 15:23 UTC

Acquisitions, Mergers, Takeovers

Paramount Defends Its Hostile Bid for Warner -- Update

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

138.36% upside

12 Months Forecast

Average 103.71 USD  138.36%

High 135 USD

Low 30 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

6

Buy

1

Hold

1

Sell

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat